# Zhejiang Starry Pharmaceutical Co. Ltd. – FDA Inspection, Sep 6, 2024

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-starry-pharmaceutical-co-ltd/bf510f18-1054-4b1a-b5de-4fe0e33b8e23
Source feed: FDA_Inspections

> FDA inspection 1252246 of Zhejiang Starry Pharmaceutical Co. Ltd., September 06, 2024. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1252246
- Company Name: Zhejiang Starry Pharmaceutical Co. Ltd.
- Inspection Date: 2024-09-06
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1098549 - 2019-08-02](https://www.keypedia.com/records/fda_inspections/zhejiang-starry-pharmaceutical-co-ltd/489fdd5b-31c0-4d9f-8ef2-36ac1fade7cd)

## Related Officers

- [Jazmine N. Brown](https://www.keypedia.com/people/jazmine-n-brown/194fc53f-942f-4e8c-a475-b7eac11be103)

Company: https://www.keypedia.com/companies/zhejiang-starry-pharmaceutical-co-ltd/eb59f9e2-22be-43f3-be3c-de1dbf375209

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c